XML 53 R43.htm IDEA: XBRL DOCUMENT v3.22.2
Subsequent Events (Details)
6 Months Ended
Sep. 30, 2022
Aug. 04, 2022
USD ($)
$ / shares
shares
Jul. 27, 2022
$ / shares
shares
Jun. 30, 2022
USD ($)
$ / shares
shares
Jul. 20, 2022
USD ($)
tranche
Dec. 31, 2021
$ / shares
shares
May 18, 2020
$ / shares
Subsequent Event [Line Items]              
Payment of milestone current | $       $ 2,250,000      
Payment of milestone non current | $       $ 1,750,000      
Common stock, par value (in dollars per share)       $ 0.001   $ 0.001  
Common shares outstanding | shares       63,753,834   63,619,140  
Engagement agreement              
Subsequent Event [Line Items]              
Common stock, par value (in dollars per share)       $ 0.001      
Series A preferred stock (if converted)              
Subsequent Event [Line Items]              
Closing price             $ 18.054
TardiMed              
Subsequent Event [Line Items]              
Number of common shares on conversion of units | shares       3,109,067      
Subsequent event              
Subsequent Event [Line Items]              
New issues | shares   66,666,667          
Subsequent event | Prefunded warrants              
Subsequent Event [Line Items]              
New issues | shares   20,083,334          
Percent of warrant becomes exercisable 20.00%   20.00%        
Share issue price   $ 0.1199          
Warrants exercise price (in dollars per share)   $ 0.0001 $ 0.0001        
Subsequent event | Common warrants              
Subsequent Event [Line Items]              
New issues | shares   46,583,333          
Share issue price   $ 0.12          
Warrants exercise price (in dollars per share)   $ 0.12          
Subsequent event | Patagonia              
Subsequent Event [Line Items]              
Number of tranches | tranche         2    
Payment of milestone current | $         $ 2,250,000    
Payment of milestone non current | $         1,750,000    
Additional to second milestone payment | $         315,000    
Total of second milestone payment | $         $ 2,065,000.000    
Subsequent event | Forecast [Member]              
Subsequent Event [Line Items]              
Proceeds from issuance of stock | $   $ 6,900,000          
Subsequent event | Forecast [Member] | TardiMed | Prefunded warrants              
Subsequent Event [Line Items]              
Warrants to purchase shares | shares     9,054,132        
Common stock, par value (in dollars per share)     $ 0.001        
Closing price     $ 0.239        
Subsequent event | Forecast [Member] | TardiMed | Series A preferred stock (if converted)              
Subsequent Event [Line Items]              
Number of common shares on conversion of units | shares     1,819